USPTO serial 78890411
CERVATEC
Reviewed by CopyMark Law Group
Reg. 3612481Status 710
- Filing date
- Status date
- Registration date
- Apr 28, 2009
- Examiner
- BUONGIORNO, CHRISTOPHER L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with CERVATEC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Heidelberg, DE
Heidelberg, DE
Heidelberg, DE
HEIDELBERG, DE
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | diagnostic preparations, reagents for scientific and medical research use, and chemical test kits comprised of reagents for chemical analyses and reagents for medical research use for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant conditions, malignant conditions, cancer and inborn errors for scientific or research use | SECTION 8 - CANCELLED | — |
| 005 | veterinary preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents and kits comprised of medical diagnostic reagents and assays for detection of cancer and neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditions, cancer and inborn errors; medical diagnostic preparations, namely, in-vitro and in-vivo diagnostic test kits comprised of medical diagnostic reagents and assays, diagnostic immunocytochemical kits comprised of medical diagnostic reagents and assays, diagnostic immunohistochemical kits comprised of medical diagnostic reagents and assays, diagnostic histology kits comprised of medical diagnostic reagents and assays, diagnostic cytology kits comprised of medical diagnostic reagents and assays, diagnostic liquid-immuno-assay kits comprised of medical diagnostic reagents and assays, diagnostic solid-phase immuno-assay kits comprised of medical diagnostic reagents and assays, point of care test kits comprised of medical diagnostic reagents and assays, diagnostic lateral-flow assay kits comprised of medical diagnostic reagents and assays, diagnostic flow-through assay kits comprised of medical diagnostic reagents and assays, diagnostic immuno-chromatographic kits comprised of medical diagnostic reagents and assays, all of the above-mentioned kits being for use in early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases; medical diagnostic test strips and diagnostic dip-stick tests for use in early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases | SECTION 8 - CANCELLED | — |
| 010 | diagnostic testing machines, namely, point-of-care testing machines for immunochemistry testing, medical diagnostic liquid-immuno-assay machines, medical diagnostic immunocytochemical machines, medical diagnostic immunohistochemical machines, medical diagnostic histology machines, medical diagnostic cytology machines, medical diagnostic solid-phase immuno assay machines, medical diagnostic ELISA testing machines, medical diagnostic immuno-chromatographic machines; diagnostic nucleic acid detection machines, diagnostic nucleic acid amplification machines, diagnostic immuno-histology machines and diagnostic immuno-cytology machines, all of the aforementioned machines being used to analyze and provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases; diagnostic equipment, apparatuses and instruments, namely, containers for medical samples, vessels, namely, containers specially designed for storing and transporting medical samples, brushes, namely, for sampling of medical samples from body cavities and epithelia; medical syringes, needles for medical use, spatulas, namely, for medical samples and medical diagnostic testing, all for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer and inborn errors | SECTION 8 - CANCELLED | — |
| 042 | scientific analysis in the fields of chemistry, biology and molecular biology; laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceutics and food technology; providing pharmaceutical research services, chemical research services, and medical diagnostic research services; research and development of pharmaceutical products and substances for others; scientific research in the nature of scientific information research services; chemical, biological, molecular biology and pharmacogenomic analysis services | SECTION 8 - CANCELLED | — |
| 044 | medical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors, detection of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors, detection of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MTM Laboratories AG
- Other trademarks owned by MTM Laboratories AG
- Other trademarks owned by MTM Laboratories AG
- Other trademarks owned by ROCHE MTM LABORATORIES AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CERVATEC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 4, 2015 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Mar 24, 2014 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Mar 24, 2014 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Apr 20, 2012 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 20, 2012 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 18, 2012 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Apr 28, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 23, 2009 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Mar 23, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 20, 2009 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Mar 20, 2009 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Sep 23, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 8, 2008 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Apr 15, 2008 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 25, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 5, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 21, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 20, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 19, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 19, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 19, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 19, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 29, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 28, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 2008 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 27, 2007 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 27, 2007 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 27, 2007 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 6, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 6, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 5, 2007 | ALIE | ASSIGNED TO LIE | — |
| Jun 27, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 27, 2007 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jun 27, 2007 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| May 31, 2007 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 31, 2007 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 25, 2006 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 25, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| May 31, 2006 | NWAP | NEW APPLICATION ENTERED | — |